These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 24134826)
1. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors. Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of erythropoietin expression in human endometrial carcinoma. Acs G; Xu X; Chu C; Acs P; Verma A Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237 [TBL] [Abstract][Full Text] [Related]
4. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796 [TBL] [Abstract][Full Text] [Related]
5. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology. Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression. Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814 [TBL] [Abstract][Full Text] [Related]
8. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111 [TBL] [Abstract][Full Text] [Related]
12. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963 [TBL] [Abstract][Full Text] [Related]
13. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions? Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268 [TBL] [Abstract][Full Text] [Related]
14. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin. Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043 [TBL] [Abstract][Full Text] [Related]
15. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle. Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle. Mannello F; Tonti GA Oncologist; 2008 Jul; 13(7):761-8. PubMed ID: 18596367 [TBL] [Abstract][Full Text] [Related]
20. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis. Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]